1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mechanical Thrombectomy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mechanical Thrombectomy Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence rate
5.2. Technological Advancements
5.3. Key Industry Events
5.4. Covid-19 Impact Analysis
6. Global Mechanical Thrombectomy Devices Market Analysis and Forecast, By Component
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Component, 2017–2031
6.3.1. Stent Retrievers
6.3.2. Aspiration Catheters/Pumps
6.3.3. Guidewires
6.3.4. Others
6.4. Market Attractiveness Analysis, By Component
7. Global Mechanical Thrombectomy Devices Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Peripheral Vascular Thrombectomy
7.3.2. Neurovascular Thrombectomy
7.4. Market Attractiveness Analysis, By Application
8. Global Mechanical Thrombectomy Devices Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals & Specialty Clinics
8.3.2. Ambulatory Surgery Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, By End-user
9. Global Mechanical Thrombectomy Devices Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Region
10. North America Mechanical Thrombectomy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Component, 2017–2031
10.2.1. Stent Retrievers
10.2.2. Aspiration Catheters/Pumps
10.2.3. Guidewires
10.2.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Peripheral Vascular Thrombectomy
10.3.2. Neurovascular Thrombectomy
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals & Specialty Clinics
10.4.2. Ambulatory Surgery Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Component
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Mechanical Thrombectomy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Component, 2017–2031
11.2.1. Stent Retrievers
11.2.2. Aspiration Catheters/Pumps
11.2.3. Guidewires
11.2.4. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Peripheral Vascular Thrombectomy
11.3.2. Neurovascular Thrombectomy
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals & Specialty Clinics
11.4.2. Ambulatory Surgery Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Component
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Mechanical Thrombectomy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component, 2017–2031
12.2.1. Stent Retrievers
12.2.2. Aspiration Catheters/Pumps
12.2.3. Guidewires
12.2.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Peripheral Vascular Thrombectomy
12.3.2. Neurovascular Thrombectomy
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals & Specialty Clinics
12.4.2. Ambulatory Surgery Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Component
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Mechanical Thrombectomy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component, 2017–2031
13.2.1. Stent Retrievers
13.2.2. Aspiration Catheters/Pumps
13.2.3. Guidewires
13.2.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Peripheral Vascular Thrombectomy
13.3.2. Neurovascular Thrombectomy
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals & Specialty Clinics
13.4.2. Ambulatory Surgery Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Component
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Mechanical Thrombectomy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component, 2017–2031
14.2.1. Stent Retrievers
14.2.2. Aspiration Catheters/Pumps
14.2.3. Guidewires
14.2.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Peripheral Vascular Thrombectomy
14.3.2. Neurovascular Thrombectomy
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals & Specialty Clinics
14.4.2. Ambulatory Surgery Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Component
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Abbott
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Becton, Dickinson & Company (BD)
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Stryker Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Merit Medical Systems, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Koninklijke Philips N.V.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Terumo Corporation
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/